Cargando…

Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer‐Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole‐Body Positron Emission Tomography

BACKGROUND: Cardiac magnetic resonance (CMR) differentiates neoplasm from thrombus via contrast enhancement; positron emission tomography (PET) assesses metabolism. The relationship between CMR contrast enhancement and metabolism on PET is unknown. METHODS AND RESULTS: The population included 121 ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Angel T., Fox, Josef, Perez Johnston, Rocio, Kim, Jiwon, Brouwer, Lillian R., Grizzard, John, Kim, Raymond J., Matasar, Mathew, Shia, Jinru, Moskowitz, Chaya S., Steingart, Richard, Weinsaft, Jonathan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585339/ https://www.ncbi.nlm.nih.gov/pubmed/31072171 http://dx.doi.org/10.1161/JAHA.118.011709

Ejemplares similares

Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer
por: Chan, Angel T., et al.
Publicado: (2017)

Pattern and Prognostic Implications of Cardiac Metastases Among Patients With Advanced Systemic Cancer Assessed With Cardiac Magnetic Resonance Imaging
por: Pun, Shawn C., et al.
Publicado: (2016)

Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity
por: Chan, Angel T., et al.
Publicado: (2021)

Tissue characteristics and anatomic distribution of cardiac metastases among patients with advanced systemic cancer assessed by cardiac magnetic resonance (CMR)
por: Pun, Shawn, et al.
Publicado: (2016)

Reply: Delivering Ethnic and Racial Diversity in Cardiac Imaging Studies of COVID-19 Patients
por: Kim, Jiwon, et al.
Publicado: (2021)

Cardiac MRI utilizing late gadolinium enhancement (LGE) and T1 mapping in the detection of radiation induced heart disease
por: Ricco, Anthony, et al.
Publicado: (2020)

Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy
por: Yu, Anthony F., et al.
Publicado: (2023)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Cardiac phase-resolved late gadolinium enhancement imaging
por: Weingärtner, Sebastian, et al.
Publicado: (2022)

Early post-contrast T1 mapping yields maximal discriminatory capacity for detection of cardiac amyloid - influence of temporal T1 differences on MOLLI imaging
por: Cooper, Mitchell A, et al.
Publicado: (2014)

Effects of gadolinium on cardiac mechanosensitivity in whole isolated swine hearts
por: Zhang, Hanyu, et al.
Publicado: (2018)

Prognostic utility of late gadolinium enhancement on cardiac magnetic resonance in cardiac amyloidosis: a meta-analysis
por: Raina, Sameer, et al.
Publicado: (2016)

Magnetic resonance imaging of cardiac sarcoidosis: an evaluation of the cardiac segments and layers that exhibit late gadolinium enhancement
por: Komada, Tomohiro, et al.
Publicado: (2016)

Mechanical effects of MitraClip on leaflet stress and myocardial strain in functional mitral regurgitation – A finite element modeling study
por: Zhang, Yue, et al.
Publicado: (2019)

Comparison of late gadolinium enhancement patterns in different forms of cardiac amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis
por: Tzogias, Leonidas, et al.
Publicado: (2009)

RASopathies and cardiac manifestations
por: Hilal, Nazia, et al.
Publicado: (2023)

Incremental diagnostic utility of delayed enhancement CMR tissue characterization for detection of catheter associated right atrial thrombus
por: Plodkowski, Andrew, et al.
Publicado: (2015)

Right ventricle late gadolinium enhancement in cardiac sarcoidosis: a case series
por: Lydell, Carmen P, et al.
Publicado: (2011)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Modeling of factors affecting late gadolinium enhancement kinetics in MRI of cardiac amyloid
por: Axel, Leon
Publicado: (2023)

Association of Right Ventricular Pressure and Volume Overload with Non-Ischemic Septal Fibrosis on Cardiac Magnetic Resonance
por: Kim, Jiwon, et al.
Publicado: (2016)

Late gadolinium enhancement and T2 MR imaging features of cardiac sarcoidosis involving the left and right ventricle
por: Cherian, Varghese, et al.
Publicado: (2009)

Cardiac manifestations of subarachnoid hemorrhage
por: Ahmadian, A, et al.
Publicado: (2013)

Myriad Cardiac Manifestation of Hyperhomocysteinemia
por: Babu, Jai, et al.
Publicado: (2015)

Can late gadolinium enhancement on cardiovascular magnetic resonance describe cardiac involvement in patients with systemic sarcoidosis and/or suspect of cardiac involvement of sarcoidosis with cardiac symptoms?
por: Kasai, Yufuko, et al.
Publicado: (2011)

Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population
por: Lander, Bradley S., et al.
Publicado: (2022)

Cardiac manifestations in patients with classical or cardiac subtype of Fabry disease
por: Wang, Wei-Ting, et al.
Publicado: (2020)

Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation – initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization
por: Wen, Yan, et al.
Publicado: (2019)

Isolated Tricuspid Regurgitation: Initial Manifestation of Cardiac Amyloidosis
por: Yoon, Dong Woog, et al.
Publicado: (2015)

Cardiac magnetic resonance left ventricular quantitative analysis post gadolinium: reliable and reproducible?
por: Rofe, Christopher J, et al.
Publicado: (2011)

Prognostic value of adenosine stress perfusion cardiac magnetic resonance with late gadolinium enhancement
por: Bertaso, Angela G, et al.
Publicado: (2011)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

Quantitative Cardiac Positron Emission Tomography: The Time Is Coming!
por: Sciagrà, Roberto
Publicado: (2012)

T1 mapping in Becker muscular dystrophy patients detects diffuse microfibrosis prior to evidence of late gadolinium enhancement or cardiac dysfunction
por: Urbinelli, Lindsay D, et al.
Publicado: (2016)

Improving Cardiac Resynchronisation Therapy
por: Thomas, George, et al.
Publicado: (2019)

Neurotoxic manifestations of high-dose intrathecal gadolinium administration for CT myelogram
por: Malalur, Pannaga, et al.
Publicado: (2020)

Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
por: Yu, Anthony F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3i4pnif2vko4i12ris97q01p3k